Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

United States Antimony (UAMY) Other Operating Expenses (2016 - 2025)

Historic Other Operating Expenses for United States Antimony (UAMY) over the last 15 years, with Q3 2025 value amounting to $469822.0.

  • United States Antimony's Other Operating Expenses fell 3326.03% to $469822.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $5.8 million, marking a year-over-year increase of 8022.3%. This contributed to the annual value of $3.8 million for FY2024, which is 8275.57% up from last year.
  • United States Antimony's Other Operating Expenses amounted to $469822.0 in Q3 2025, which was down 3326.03% from $2.0 million recorded in Q2 2025.
  • United States Antimony's 5-year Other Operating Expenses high stood at $2.0 million for Q2 2025, and its period low was $100427.0 during Q3 2021.
  • Its 5-year average for Other Operating Expenses is $600928.9, with a median of $336475.0 in 2023.
  • Its Other Operating Expenses has fluctuated over the past 5 years, first plummeted by 4812.14% in 2022, then surged by 31674.64% in 2023.
  • Over the past 5 years, United States Antimony's Other Operating Expenses (Quarter) stood at $198567.0 in 2021, then soared by 49.81% to $297467.0 in 2022, then skyrocketed by 316.75% to $1.2 million in 2023, then soared by 49.23% to $1.8 million in 2024, then tumbled by 74.6% to $469822.0 in 2025.
  • Its Other Operating Expenses stands at $469822.0 for Q3 2025, versus $2.0 million for Q2 2025 and $1.5 million for Q1 2025.